Page 5 - Vector Center News Today

To date, 3,591,066 coronavirus cases have been confirmed in Russia, with 2,978,764 patients having recovered from the disease

Belarus starts vaccination against COVID using Russia’s Sputnik V Maxim Velichko 27 https://static.news.ru/photo/bd0c6a48-49a7-11eb-af41-fa163e074e61_660.jpg Photo: Sergey Kiselev/Moscow Belarus Healthcare Minist...

So for, two domestically-developed anti-coronavirus vaccines have been registered in Russia MOSCOW, December 18. /TASS/. Russia and Germany will soon hold talks on possible joint production of Russian anti-coronavirus vaccines, the press service of the Russian health ministry said on Friday after Minister Mikhail Murashko’s telephone conversation with his German counterpart, Jens Spahn. "As was agreed, Russian and German experts will soon hold working talks to try to find production facilitie...

Russian HIV vaccine capable of generating antibodies - Vector Center MOSCOW. Dec 18 (Interfax) - The human immunodeficiency virus (HIV) vaccine developed by the Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) is capable of generating antibodies, which is proven by 100% of volunteers participating in phase 1 of clinical trials, Vector told Interfax on Friday. "HIV-specific antib...

MOSCOW, December 17. /TASS/. The effectiveness of Russia’s coronavirus vaccine is 97%, President of Russia Vladimir Putin said at his annual press conference on Thursday. "Russia is the first country in the world, which has invented, we could say, and started to produce the vaccine of both the Gamaleya scientific institute and the Novosibirsk-based Vector center. And we have a good vaccine [that is] both safe and effective - 95% and higher - and specialists say its level of protection reaches...

AstraZeneca and Russia’s Sputnik V lab to share data in seeking coronavirus vaccine advances Robyn Dixon, Rick Noack © Justin Tallis/AFP/Getty Images An illustration image on Nov. 17, 2020 shows vials and syringes with the logo of the Anglo-Swedish pharmaceutical company AstraZeneca, which developed its vaccine in collaboration with the University of Oxford. MOSCOW —The developers of Russias Sputnik V vaccine will share science with pharmaceutical giant AstraZeneca to e...